Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • papori
    Senior Member
    • Dec 2010
    • 181

    #1

    trans abyss assembly

    hey all, i am using trans abyss for de novo assembly.
    When i am running the assembly level for k=26(example) i am getting this kind of output:

    >11 3814 208317 9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+
    CTTGGTGAATTGGCTCCCGAAGCTCCTGCTGCTTGGAGTGGGTGACCT......

    can anyone explain me What does the numbers in the " > " line means?


    thanks in advance...
  • burt
    Junior Member
    • Jan 2011
    • 8

    #2
    Hey, I've been playing around with trans-abyss for RNA-seq data. Erm, what mode/stage of trans-abyss did you ran? I don't seem to remember coming across those kind of output for trans-abyss.

    In fact trans-abyss has a specific output folder for each stage of the pipeline. This is described in the flow diagram of the trans-abyss pipeline in their paper.

    Comment

    • papori
      Senior Member
      • Dec 2010
      • 181

      #3
      thanks mate, i got the answer already in trans abyss group..

      For this line:

      >11 3814 208317 9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+
      It means this contig ID is 11, its length is 3814, its kmer coverage is 208317, and the final string "9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+" is the path of contig nodes that made up this contig.
      Rong

      Comment

      • blindtiger454
        Member
        • Oct 2010
        • 30

        #4
        it's a little off subject, but I've been curious about using trans abyss. How does the program output transcript variants of the same gene? Newbler uses the isogroup & isotig style, and I've heard velvet/oases uses a similar description. Can trans abyss do the same thing, labeling at the transcript and gene level?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...